Market opportunities lie in enhancing risk-based V&V planning, focusing on DQ, IQ, OQ, and PQs to address cGMP deficiencies and regulatory expectations. By aligning with FDA, ICH, and ISO standards, ...
TUSTIN, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to ...
WEST SACRAMENTO, Calif., March 28, 2023 /PRNewswire/ -- Gemini Bioproducts, LLC ("GeminiBio"), a leading manufacturer of cell culture products and custom cGMP bioprocess liquids for the biotech ...
Industry practice has changed radically over the past five decades. Can laws published in the 1960s still ensure pharmaceutical quality and safety today? In the pharmaceutical industry, it often takes ...
The partnership addressed complex peptide synthesis and purification challenges to achieve high yield and purity suitable for clinical use BEVERLY HILLS, California, Oct. 20, 2025 (GLOBE NEWSWIRE) -- ...
Our Cell Processing Facility (CPF) is a Good Manufacturing Practice, or GMP, bioprocessing manufacturing facility that supports the reproducible production of human hematopoietic or immune-competent ...
PITTSBURGH, Nov. 7, 2019 /PRNewswire/ -- Thar Process, founded in 1990, announced today that after years of holding a Certified Organic certificate for algae extraction, it now holds the same for hemp ...
BEVERLY HILLS, California, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Orocidin A/S (“Orocidin”), a subsidiary of Nordicus Partners Corporation (NORD) (“Nordicus” or the “Company”), a financial consulting ...
TUSTIN, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback